Clinical Course of Arrhythmogenic Right Ventricular Cardiomyopathy in the Era of Implantable Cardioverter-Defibrillators and Radiofrequency Catheter Ablation
This study investigated the clinical course of arrhythmogenic right ventricular cardiomyopathy (ARVC) patients and in particular evaluated the contribution of radiofrequency catheter ablation (RFCA) and an implantable cardioverter-defibrillator (ICD) to the treatment of ARVC. ARVC is a myocardial di...
Gespeichert in:
| Veröffentlicht in: | International Heart Journal 2010, Vol.51(1), pp.34-40 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 40 |
|---|---|
| container_issue | 1 |
| container_start_page | 34 |
| container_title | International Heart Journal |
| container_volume | 51 |
| creator | Komura, Masatoshi Suzuki, Jun-ichi Adachi, Susumu Takahashi, Atsushi Otomo, Kenichiro Nitta, Junichi Nishizaki, Mitsuhiro Obayashi, Tohru Nogami, Akihiko Satoh, Yasuhiro Okishige, Kaoru Hachiya, Hitoshi Hirao, Kenzo Isobe, Mitsuaki |
| description | This study investigated the clinical course of arrhythmogenic right ventricular cardiomyopathy (ARVC) patients and in particular evaluated the contribution of radiofrequency catheter ablation (RFCA) and an implantable cardioverter-defibrillator (ICD) to the treatment of ARVC. ARVC is a myocardial disorder and a cause of sudden cardiac death due to ventricular tachycardia (VT). Little is known about its prognosis in Japanese ARVC patients. Thirty-five ARVC patients were studied. Mean age of patients whose onset of ARVC was congestive heart failure (CHF) (66.0 ± 4.0 years) was significantly higher than those whose onset was VT (44.5 ± 14.8 years, P < 0.05). ARVC patients with CHF onset showed significantly higher death rates compared to those with VT onset. ICD treatment significantly reduced episodes of hospitalization due to VT (0.1 ± 0.4 episodes) in comparison to treatment by RFCA (1.7 ± 2.2 episodes, P < 0.03). RFCA treatment did not reduce recurrence of VT in the follow-up period. ICD therapy showed comparable mortality to RFCA treatment. The prognosis of ARVC with CHF onset is poor. ICD therapy significantly reduced hospitalization due to VT compared with RFCA treatment. ICD implantation in combination with medication may be a better treatment for ARVC. |
| doi_str_mv | 10.1536/ihj.51.34 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733580772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733580772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-3caebca91477b10df9d09353d1142d360fdfb610e009c35a0a68509ff52cff703</originalsourceid><addsrcrecordid>eNo90cFq3DAQBmBRWpo07aEvUHQrPXgrWZYdXwqLk6aBQCG0vZqxPFprsa3tSA74YfquVdjNXiTB_-lnkBj7KMVGalV-dcN-o-VGFa_YpVRFnam8rl-fzrkq9QV7F8JeiEJqUb1lF7mQhU7hJfvXjG52Bkbe-IUCcm_5lmhY4zD5HaaIP7rdEPkfnCM5s4xAvAHqnZ9Wf4A4rNzNPA7Ibwmeb99PhxHmCN2IJ_iEFJGyG7SuIzeOED0FDnPPHyHFlvDvgrNZE089ifJtl5Dz83v2xsIY8MNpv2K_v9_-an5kDz_v7pvtQ2Z0LmOmDGBnoJZFVXVS9LbuRa206qUs8l6Vwva2K6VAIWqjNAgor7WordW5sbYS6op9PvYeyKdZQmwnFwymUWf0S2grpfS1qKo8yS9HaciHQGjbA7kJaG2laJ8_o02f0WrZqiLZT6fWpZuwP8uX10_g2xHsQ4QdngFQdGbElyp5XFRxDswA1OKs_gNZqZ-K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733580772</pqid></control><display><type>article</type><title>Clinical Course of Arrhythmogenic Right Ventricular Cardiomyopathy in the Era of Implantable Cardioverter-Defibrillators and Radiofrequency Catheter Ablation</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Komura, Masatoshi ; Suzuki, Jun-ichi ; Adachi, Susumu ; Takahashi, Atsushi ; Otomo, Kenichiro ; Nitta, Junichi ; Nishizaki, Mitsuhiro ; Obayashi, Tohru ; Nogami, Akihiko ; Satoh, Yasuhiro ; Okishige, Kaoru ; Hachiya, Hitoshi ; Hirao, Kenzo ; Isobe, Mitsuaki</creator><creatorcontrib>Komura, Masatoshi ; Suzuki, Jun-ichi ; Adachi, Susumu ; Takahashi, Atsushi ; Otomo, Kenichiro ; Nitta, Junichi ; Nishizaki, Mitsuhiro ; Obayashi, Tohru ; Nogami, Akihiko ; Satoh, Yasuhiro ; Okishige, Kaoru ; Hachiya, Hitoshi ; Hirao, Kenzo ; Isobe, Mitsuaki</creatorcontrib><description>This study investigated the clinical course of arrhythmogenic right ventricular cardiomyopathy (ARVC) patients and in particular evaluated the contribution of radiofrequency catheter ablation (RFCA) and an implantable cardioverter-defibrillator (ICD) to the treatment of ARVC. ARVC is a myocardial disorder and a cause of sudden cardiac death due to ventricular tachycardia (VT). Little is known about its prognosis in Japanese ARVC patients. Thirty-five ARVC patients were studied. Mean age of patients whose onset of ARVC was congestive heart failure (CHF) (66.0 ± 4.0 years) was significantly higher than those whose onset was VT (44.5 ± 14.8 years, P < 0.05). ARVC patients with CHF onset showed significantly higher death rates compared to those with VT onset. ICD treatment significantly reduced episodes of hospitalization due to VT (0.1 ± 0.4 episodes) in comparison to treatment by RFCA (1.7 ± 2.2 episodes, P < 0.03). RFCA treatment did not reduce recurrence of VT in the follow-up period. ICD therapy showed comparable mortality to RFCA treatment. The prognosis of ARVC with CHF onset is poor. ICD therapy significantly reduced hospitalization due to VT compared with RFCA treatment. ICD implantation in combination with medication may be a better treatment for ARVC.</description><identifier>ISSN: 1349-2365</identifier><identifier>EISSN: 1349-3299</identifier><identifier>DOI: 10.1536/ihj.51.34</identifier><identifier>PMID: 20145349</identifier><language>eng</language><publisher>Japan: International Heart Journal Association</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Arrhythmia Agents - therapeutic use ; Arrhythmogenic right ventricular cardiomyopathy ; Arrhythmogenic Right Ventricular Dysplasia - complications ; Arrhythmogenic Right Ventricular Dysplasia - drug therapy ; Arrhythmogenic Right Ventricular Dysplasia - surgery ; Catheter Ablation ; Defibrillators, Implantable ; Female ; Heart Failure - etiology ; Humans ; Implantable cardioverter-defibrillator ; Male ; Middle Aged ; Retrospective Studies ; Tachycardia, Ventricular - etiology ; Tachycardia, Ventricular - therapy ; Treatment Outcome ; Ventricular tachycardia ; Young Adult</subject><ispartof>International Heart Journal, 2010, Vol.51(1), pp.34-40</ispartof><rights>2010 by the International Heart Journal Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-3caebca91477b10df9d09353d1142d360fdfb610e009c35a0a68509ff52cff703</citedby><cites>FETCH-LOGICAL-c521t-3caebca91477b10df9d09353d1142d360fdfb610e009c35a0a68509ff52cff703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,1879,4012,27910,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20145349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Komura, Masatoshi</creatorcontrib><creatorcontrib>Suzuki, Jun-ichi</creatorcontrib><creatorcontrib>Adachi, Susumu</creatorcontrib><creatorcontrib>Takahashi, Atsushi</creatorcontrib><creatorcontrib>Otomo, Kenichiro</creatorcontrib><creatorcontrib>Nitta, Junichi</creatorcontrib><creatorcontrib>Nishizaki, Mitsuhiro</creatorcontrib><creatorcontrib>Obayashi, Tohru</creatorcontrib><creatorcontrib>Nogami, Akihiko</creatorcontrib><creatorcontrib>Satoh, Yasuhiro</creatorcontrib><creatorcontrib>Okishige, Kaoru</creatorcontrib><creatorcontrib>Hachiya, Hitoshi</creatorcontrib><creatorcontrib>Hirao, Kenzo</creatorcontrib><creatorcontrib>Isobe, Mitsuaki</creatorcontrib><title>Clinical Course of Arrhythmogenic Right Ventricular Cardiomyopathy in the Era of Implantable Cardioverter-Defibrillators and Radiofrequency Catheter Ablation</title><title>International Heart Journal</title><addtitle>Int. Heart J.</addtitle><description>This study investigated the clinical course of arrhythmogenic right ventricular cardiomyopathy (ARVC) patients and in particular evaluated the contribution of radiofrequency catheter ablation (RFCA) and an implantable cardioverter-defibrillator (ICD) to the treatment of ARVC. ARVC is a myocardial disorder and a cause of sudden cardiac death due to ventricular tachycardia (VT). Little is known about its prognosis in Japanese ARVC patients. Thirty-five ARVC patients were studied. Mean age of patients whose onset of ARVC was congestive heart failure (CHF) (66.0 ± 4.0 years) was significantly higher than those whose onset was VT (44.5 ± 14.8 years, P < 0.05). ARVC patients with CHF onset showed significantly higher death rates compared to those with VT onset. ICD treatment significantly reduced episodes of hospitalization due to VT (0.1 ± 0.4 episodes) in comparison to treatment by RFCA (1.7 ± 2.2 episodes, P < 0.03). RFCA treatment did not reduce recurrence of VT in the follow-up period. ICD therapy showed comparable mortality to RFCA treatment. The prognosis of ARVC with CHF onset is poor. ICD therapy significantly reduced hospitalization due to VT compared with RFCA treatment. ICD implantation in combination with medication may be a better treatment for ARVC.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Arrhythmogenic right ventricular cardiomyopathy</subject><subject>Arrhythmogenic Right Ventricular Dysplasia - complications</subject><subject>Arrhythmogenic Right Ventricular Dysplasia - drug therapy</subject><subject>Arrhythmogenic Right Ventricular Dysplasia - surgery</subject><subject>Catheter Ablation</subject><subject>Defibrillators, Implantable</subject><subject>Female</subject><subject>Heart Failure - etiology</subject><subject>Humans</subject><subject>Implantable cardioverter-defibrillator</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Tachycardia, Ventricular - etiology</subject><subject>Tachycardia, Ventricular - therapy</subject><subject>Treatment Outcome</subject><subject>Ventricular tachycardia</subject><subject>Young Adult</subject><issn>1349-2365</issn><issn>1349-3299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90cFq3DAQBmBRWpo07aEvUHQrPXgrWZYdXwqLk6aBQCG0vZqxPFprsa3tSA74YfquVdjNXiTB_-lnkBj7KMVGalV-dcN-o-VGFa_YpVRFnam8rl-fzrkq9QV7F8JeiEJqUb1lF7mQhU7hJfvXjG52Bkbe-IUCcm_5lmhY4zD5HaaIP7rdEPkfnCM5s4xAvAHqnZ9Wf4A4rNzNPA7Ibwmeb99PhxHmCN2IJ_iEFJGyG7SuIzeOED0FDnPPHyHFlvDvgrNZE089ifJtl5Dz83v2xsIY8MNpv2K_v9_-an5kDz_v7pvtQ2Z0LmOmDGBnoJZFVXVS9LbuRa206qUs8l6Vwva2K6VAIWqjNAgor7WordW5sbYS6op9PvYeyKdZQmwnFwymUWf0S2grpfS1qKo8yS9HaciHQGjbA7kJaG2laJ8_o02f0WrZqiLZT6fWpZuwP8uX10_g2xHsQ4QdngFQdGbElyp5XFRxDswA1OKs_gNZqZ-K</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Komura, Masatoshi</creator><creator>Suzuki, Jun-ichi</creator><creator>Adachi, Susumu</creator><creator>Takahashi, Atsushi</creator><creator>Otomo, Kenichiro</creator><creator>Nitta, Junichi</creator><creator>Nishizaki, Mitsuhiro</creator><creator>Obayashi, Tohru</creator><creator>Nogami, Akihiko</creator><creator>Satoh, Yasuhiro</creator><creator>Okishige, Kaoru</creator><creator>Hachiya, Hitoshi</creator><creator>Hirao, Kenzo</creator><creator>Isobe, Mitsuaki</creator><general>International Heart Journal Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Clinical Course of Arrhythmogenic Right Ventricular Cardiomyopathy in the Era of Implantable Cardioverter-Defibrillators and Radiofrequency Catheter Ablation</title><author>Komura, Masatoshi ; Suzuki, Jun-ichi ; Adachi, Susumu ; Takahashi, Atsushi ; Otomo, Kenichiro ; Nitta, Junichi ; Nishizaki, Mitsuhiro ; Obayashi, Tohru ; Nogami, Akihiko ; Satoh, Yasuhiro ; Okishige, Kaoru ; Hachiya, Hitoshi ; Hirao, Kenzo ; Isobe, Mitsuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-3caebca91477b10df9d09353d1142d360fdfb610e009c35a0a68509ff52cff703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Arrhythmogenic right ventricular cardiomyopathy</topic><topic>Arrhythmogenic Right Ventricular Dysplasia - complications</topic><topic>Arrhythmogenic Right Ventricular Dysplasia - drug therapy</topic><topic>Arrhythmogenic Right Ventricular Dysplasia - surgery</topic><topic>Catheter Ablation</topic><topic>Defibrillators, Implantable</topic><topic>Female</topic><topic>Heart Failure - etiology</topic><topic>Humans</topic><topic>Implantable cardioverter-defibrillator</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Tachycardia, Ventricular - etiology</topic><topic>Tachycardia, Ventricular - therapy</topic><topic>Treatment Outcome</topic><topic>Ventricular tachycardia</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Komura, Masatoshi</creatorcontrib><creatorcontrib>Suzuki, Jun-ichi</creatorcontrib><creatorcontrib>Adachi, Susumu</creatorcontrib><creatorcontrib>Takahashi, Atsushi</creatorcontrib><creatorcontrib>Otomo, Kenichiro</creatorcontrib><creatorcontrib>Nitta, Junichi</creatorcontrib><creatorcontrib>Nishizaki, Mitsuhiro</creatorcontrib><creatorcontrib>Obayashi, Tohru</creatorcontrib><creatorcontrib>Nogami, Akihiko</creatorcontrib><creatorcontrib>Satoh, Yasuhiro</creatorcontrib><creatorcontrib>Okishige, Kaoru</creatorcontrib><creatorcontrib>Hachiya, Hitoshi</creatorcontrib><creatorcontrib>Hirao, Kenzo</creatorcontrib><creatorcontrib>Isobe, Mitsuaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International Heart Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Komura, Masatoshi</au><au>Suzuki, Jun-ichi</au><au>Adachi, Susumu</au><au>Takahashi, Atsushi</au><au>Otomo, Kenichiro</au><au>Nitta, Junichi</au><au>Nishizaki, Mitsuhiro</au><au>Obayashi, Tohru</au><au>Nogami, Akihiko</au><au>Satoh, Yasuhiro</au><au>Okishige, Kaoru</au><au>Hachiya, Hitoshi</au><au>Hirao, Kenzo</au><au>Isobe, Mitsuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Course of Arrhythmogenic Right Ventricular Cardiomyopathy in the Era of Implantable Cardioverter-Defibrillators and Radiofrequency Catheter Ablation</atitle><jtitle>International Heart Journal</jtitle><addtitle>Int. Heart J.</addtitle><date>2010</date><risdate>2010</risdate><volume>51</volume><issue>1</issue><spage>34</spage><epage>40</epage><pages>34-40</pages><issn>1349-2365</issn><eissn>1349-3299</eissn><abstract>This study investigated the clinical course of arrhythmogenic right ventricular cardiomyopathy (ARVC) patients and in particular evaluated the contribution of radiofrequency catheter ablation (RFCA) and an implantable cardioverter-defibrillator (ICD) to the treatment of ARVC. ARVC is a myocardial disorder and a cause of sudden cardiac death due to ventricular tachycardia (VT). Little is known about its prognosis in Japanese ARVC patients. Thirty-five ARVC patients were studied. Mean age of patients whose onset of ARVC was congestive heart failure (CHF) (66.0 ± 4.0 years) was significantly higher than those whose onset was VT (44.5 ± 14.8 years, P < 0.05). ARVC patients with CHF onset showed significantly higher death rates compared to those with VT onset. ICD treatment significantly reduced episodes of hospitalization due to VT (0.1 ± 0.4 episodes) in comparison to treatment by RFCA (1.7 ± 2.2 episodes, P < 0.03). RFCA treatment did not reduce recurrence of VT in the follow-up period. ICD therapy showed comparable mortality to RFCA treatment. The prognosis of ARVC with CHF onset is poor. ICD therapy significantly reduced hospitalization due to VT compared with RFCA treatment. ICD implantation in combination with medication may be a better treatment for ARVC.</abstract><cop>Japan</cop><pub>International Heart Journal Association</pub><pmid>20145349</pmid><doi>10.1536/ihj.51.34</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1349-2365 |
| ispartof | International Heart Journal, 2010, Vol.51(1), pp.34-40 |
| issn | 1349-2365 1349-3299 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733580772 |
| source | J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Adolescent Adult Aged Anti-Arrhythmia Agents - therapeutic use Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic Right Ventricular Dysplasia - complications Arrhythmogenic Right Ventricular Dysplasia - drug therapy Arrhythmogenic Right Ventricular Dysplasia - surgery Catheter Ablation Defibrillators, Implantable Female Heart Failure - etiology Humans Implantable cardioverter-defibrillator Male Middle Aged Retrospective Studies Tachycardia, Ventricular - etiology Tachycardia, Ventricular - therapy Treatment Outcome Ventricular tachycardia Young Adult |
| title | Clinical Course of Arrhythmogenic Right Ventricular Cardiomyopathy in the Era of Implantable Cardioverter-Defibrillators and Radiofrequency Catheter Ablation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T03%3A00%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Course%20of%20Arrhythmogenic%20Right%20Ventricular%20Cardiomyopathy%20in%20the%20Era%20of%20Implantable%20Cardioverter-Defibrillators%20and%20Radiofrequency%20Catheter%20Ablation&rft.jtitle=International%20Heart%20Journal&rft.au=Komura,%20Masatoshi&rft.date=2010&rft.volume=51&rft.issue=1&rft.spage=34&rft.epage=40&rft.pages=34-40&rft.issn=1349-2365&rft.eissn=1349-3299&rft_id=info:doi/10.1536/ihj.51.34&rft_dat=%3Cproquest_cross%3E733580772%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733580772&rft_id=info:pmid/20145349&rfr_iscdi=true |